Rivaroxaban Tablets, USP, 2.5MG
Anticoagulant (Factor Xa Inhibitor)
Used for reduction of risk of major cardiovascular events in patients with Coronary Artery Disease (CAD); Reduction of risk of major thrombotic vascular events in patients with Peripheral Artery Disease (PAD), including patients after lower extremity revascularization due to symptomatic PAD
Light, yellow-colored biconvex round tablet debossed with “7C” on one side and plain on the other side
